KR970005016A - 2'-데옥시-2 -메틸리덴시티딘 이수화물 함유 조성물 - Google Patents

2'-데옥시-2 -메틸리덴시티딘 이수화물 함유 조성물 Download PDF

Info

Publication number
KR970005016A
KR970005016A KR1019960017263A KR19960017263A KR970005016A KR 970005016 A KR970005016 A KR 970005016A KR 1019960017263 A KR1019960017263 A KR 1019960017263A KR 19960017263 A KR19960017263 A KR 19960017263A KR 970005016 A KR970005016 A KR 970005016A
Authority
KR
South Korea
Prior art keywords
acid
deoxy
aqueous solution
dihydrate
group
Prior art date
Application number
KR1019960017263A
Other languages
English (en)
Other versions
KR0174212B1 (ko
Inventor
신지 사까따
다까노리 미야시따
가즈히꼬 곤도
아쓰시 사까이
도시유끼 시바따
다까유끼 오가와
Original Assignee
고오야 마사시
요시또미세이야꾸 가부시끼가이샤
하마구찌 미찌오
야마사소유 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 고오야 마사시, 요시또미세이야꾸 가부시끼가이샤, 하마구찌 미찌오, 야마사소유 가부시끼가이샤 filed Critical 고오야 마사시
Publication of KR970005016A publication Critical patent/KR970005016A/ko
Application granted granted Critical
Publication of KR0174212B1 publication Critical patent/KR0174212B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

2'-데옥시-2 -메틸리덴시티딘 이수화물 및 글루코스, D - 소르비톨, D - 만니톨, 락토오스, 프락토스 및 슈크로스로 구성된 군으로부터 선택되는 당류를 함유하는 조성물이 개시되어 있다.

Description

2'-데옥시-2 -메틸리덴시티딘 이수화물 함유 조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (9)

  1. 2'-데옥시-2'-메틸리덴시티딘 이수화물 및 글루코스, D-소르비톨, D-만니톨, 락토오스, 프락토스 및 슈크로스로 구성된 군으로부터 선택되는 당류를 함유하는 조성물.
  2. 제1항에 있어서, 액체 제제를 제형화하는데 있어 용해 매질로서 유기산 수용액이 사용되는 조성물.
  3. 제2항에 있어서, 유기산 수용액이 락트산, 시트르산, 말레산, 타르타르산 및 아세트산으로 구성된 군으로부터 선택한 1 종류 이상을 함유하는 조성물.
  4. 2'-데옥시-2'-메틸리덴시티딘 이수화물 및 글루코스, D-소르비톨, D-만니톨, 락토오스, 프락토스 및 슈크로스로 구성된 군으로부터 선택되는 당류를 함유하는 수용액을 동결 건조시켜 수득한 조성물.
  5. 제4항에 있어서, 액체 제제를 제형화하는데 있어 용해 매질로서 유기산 수용액이 사용되는 조성물.
  6. 제5항에 있어서, 유기산 수용액이 락트산, 시트르산, 말레산, 타르타르산 및 아세트산으로 구성된 군으로부터 선택한 1 종류 이상을 함유하는 조성물.
  7. 2'-데옥시-2'-메틸리덴시티딘 이수화물 및 글루코스, D-소르비톨, D-만니톨, 락토오스, 프락토스 및 슈크로스로 구성된 군으로부터 선택되는 당류를 함께 공-분쇄하여 수득한 조성물.
  8. 제7항에 있어서, 액체 제제를 제형화하는데 있어 용해 매질로서 유기산 수용액이 사용되는 조성물.
  9. 제8항에 있어서, 유기산 수용액이 락트산, 시트르산, 말레산, 타르타르산 및 아세트산으로 구성된 군으로부터 선택한 1 종류 이상을 함유하는 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019960017263A 1990-02-19 1996-05-21 2'-데옥시-2'-메틸리덴시티딘 이수화물 함유 조성물 KR0174212B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2037695A JPH0615557B2 (ja) 1990-02-19 1990-02-19 ２’―デオキシ―２’―メチリデンシチジンの２水和物結晶
JP90-37695 1990-02-19
KR1019910002636A KR960010947B1 (ko) 1990-02-19 1991-02-19 2'-데옥시-2'메틸리덴시티딘 이수화물 이의 제조방법 및 조성물

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1019910002636A Division KR960010947B1 (ko) 1990-02-19 1991-02-19 2'-데옥시-2'메틸리덴시티딘 이수화물 이의 제조방법 및 조성물

Publications (2)

Publication Number Publication Date
KR970005016A true KR970005016A (ko) 1997-01-29
KR0174212B1 KR0174212B1 (ko) 1999-02-01

Family

ID=12504690

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1019910002636A KR960010947B1 (ko) 1990-02-19 1991-02-19 2'-데옥시-2'메틸리덴시티딘 이수화물 이의 제조방법 및 조성물
KR1019960017263A KR0174212B1 (ko) 1990-02-19 1996-05-21 2'-데옥시-2'-메틸리덴시티딘 이수화물 함유 조성물

Family Applications Before (1)

Application Number Title Priority Date Filing Date
KR1019910002636A KR960010947B1 (ko) 1990-02-19 1991-02-19 2'-데옥시-2'메틸리덴시티딘 이수화물 이의 제조방법 및 조성물

Country Status (9)

Country Link
US (2) US5183882A (ko)
EP (1) EP0443471B1 (ko)
JP (1) JPH0615557B2 (ko)
KR (2) KR960010947B1 (ko)
AT (1) ATE118012T1 (ko)
CA (1) CA2036507C (ko)
DE (1) DE69107098T2 (ko)
DK (1) DK0443471T3 (ko)
ES (1) ES2067780T3 (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5401726A (en) * 1988-08-25 1995-03-28 Yoshitomi Pharaceutical Industries, Ltd. 2'methylidenepyrimidine nucleoside compounds, their use and method for production thereof
JPH0615557B2 (ja) * 1990-02-19 1994-03-02 ヤマサ醤油株式会社 ２’―デオキシ―２’―メチリデンシチジンの２水和物結晶
US5589587A (en) * 1992-05-12 1996-12-31 Merrell Pharmaceuticals Inc. Process for the preparation of ribonucleotide reductase inhibitors
SK281684B6 (sk) * 1993-08-19 2001-06-11 Merck & Co., Inc. Hemihydrát kryštalickej soli 4''-deoxy-4''-epimetylaminoavermektínu b1a/b1b s kyselinou benzoovou, spôsob jeho výroby a prostriedok s jeho obsahom
EP0738273B1 (en) * 1994-01-07 1999-11-17 Merrell Pharmaceuticals Inc. Monohydrate of (e)-2'-deoxy-2'-(fluoromethylene)cytidine
US5811408A (en) * 1994-07-12 1998-09-22 Yamasa Corporation 2'-deoxy-2'-(substituted or unsubstituted)methylidene-4'-thionucleosides
US5665711A (en) * 1995-12-12 1997-09-09 Yoshitomi Pharmaceutical Industries, Ltd. Antitumor composition for oral administration
EP2106788A1 (en) * 2008-04-04 2009-10-07 Ipsen Pharma Liquid and freeze dried formulations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE124702T1 (de) * 1987-03-19 1995-07-15 Yamasa Shoyu Kk 2'-alkyliden-pyrimidin-nukleosid-derivate, verfahren zur herstellung und verwendung.
JPS63258818A (ja) * 1987-04-16 1988-10-26 Yoshitomi Pharmaceut Ind Ltd 制ガン剤
DE68922899T2 (de) * 1988-12-07 1995-10-12 Yoshitomi Pharmaceutical Verbindungen von Pyrimidin 2'-Methylidin Nukleosiden.
JPH0615557B2 (ja) * 1990-02-19 1994-03-02 ヤマサ醤油株式会社 ２’―デオキシ―２’―メチリデンシチジンの２水和物結晶

Also Published As

Publication number Publication date
CA2036507C (en) 1996-09-10
ES2067780T3 (es) 1995-04-01
DE69107098D1 (de) 1995-03-16
CA2036507A1 (en) 1991-08-20
ATE118012T1 (de) 1995-02-15
JPH0615557B2 (ja) 1994-03-02
KR910021351A (ko) 1991-12-20
KR960010947B1 (ko) 1996-08-14
US5183882A (en) 1993-02-02
DK0443471T3 (da) 1995-06-26
EP0443471B1 (en) 1995-02-01
US5412089A (en) 1995-05-02
JPH03240794A (ja) 1991-10-28
EP0443471A1 (en) 1991-08-28
DE69107098T2 (de) 1995-06-29
KR0174212B1 (ko) 1999-02-01

Similar Documents

Publication Publication Date Title
DK0480640T3 (da) Lactoneotrehalose, fremstilling deraf og anvendelse deraf
ES2140507T3 (es) Oligosacaridos no reductores, su preparacion y su utilizacion.
RU92016283A (ru) Производные и аналоги 2-дезокси-2,3-дидегидро-n-ацетилнеураминовой кислоты, способ их получения, их использование в качестве антивирусных агентов, фармацевтическая композиция, способ лечения
KR970005016A (ko) 2'-데옥시-2 -메틸리덴시티딘 이수화물 함유 조성물
KR930001887A (ko) 치과용 석고 조성물
CA2292226A1 (en) Chlorhexidine formulations, new chlorhexidine salts, solutions containing these and their use
DK468288A (da) Antivirale forbindelser
ES2108129T3 (es) Nuevos derivados de pirazina, su preparacion y empleo.
KR830000911A (ko) X-선 콘트라스트제제의 살균된 주사용의 생리적으로 가능한 용액의 제조방법 및 x-선콘트라스트 제제 및 완충액
SE7711853L (sv) Stabiliserade flytande kompositioner av enzymer och koenzymer samt sett for deras framstellning
IE40957L (en) 4- o-ó,d-glucopyranosyl -6-o-ó,d- xylohexopyranosyl -2-¹deoxystreptamine
KR910021394A (ko) 카르복실산 유도체
JPS6431727A (en) Dissolution of argininamide and drug composition containing argininamides
KR890002103A (ko) 피페리딘 유도체, 그의제법 및 도르지발 38
CO5580745A2 (es) Composicion antihelmitica
NO903058D0 (no) Farmasoeytisk preparat med forbedret absorberbarhet.
KR870001269A (ko) 수성 액체 반응성 염료 조성물
LU79622A1 (fr) Procede de preparation d'une composition detergente liquide aqueuse
KR870008857A (ko) 인데노피리미딘 유도체
JPS54105221A (en) Preparation of stable concentrated dopa injection
JPS543077A (en) Preparation of butyrophenone derivatives
KR910015584A (ko) 7-아미노-3-메톡시메틸세프-3-엠-4-카복실산의 제조방법
US3485922A (en) Injectable solutions of the tri-(hydroxymethyl)-aminomethane derivative of 3-(alpha-acetonylbenzyl)-4-hydroxycoumarin and processes for preparing the same
JPS53149985A (en) Preparation of 5-fluorouracil derivatives
SE9002508D0 (sv) Asymmetric synthesis of furo (3,4-c) pyridine derivatives

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee